Back to Search
GARY REICHARD, M.D.
M.D.
Family Medicine Physician
NPI: 1235195017IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
31705(AZ)MD60404371(WA)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE
Class of 1980
Research & Publications (15)
Discovery of a novel, potent and orally active series of gamma-lactams as selective NK1 antagonists.
PMID 18547807·Bioorg Med Chem Lett·2008
8-other
An efficient approach for the rapid assessment of oral rat exposures for new chemical entities in drug discovery.
PMID 16732590·J Pharm Sci·2006
7-preclinical
Cyclobutane derivatives as potent NK1 selective antagonists.
PMID 16682196·Bioorg Med Chem Lett·2006
7-preclinical
Cyclic urea derivatives as potent NK1 selective antagonists. Part II: Effects of fluoro and benzylic methyl substitutions.
PMID 16290143·Bioorg Med Chem Lett·2006
7-preclinical
Cyclic urea derivatives as potent NK1 selective antagonists.
PMID 16019209·Bioorg Med Chem Lett·2005
7-preclinical
Asymmetric synthesis of 4,4-disubstituted-2-imidazoli-dinones: potent NK1 antagonists.
PMID 14601972·Org Lett·2003
8-other
Development and potential utility of dual and triple NK receptor antagonists.
PMID 12871172·Curr Top Med Chem·2003
6-review
SCH 206272: a potent, orally active tachykinin NK(1), NK(2), and NK(3) receptor antagonist.
PMID 12206858·Eur J Pharmacol·2002
4-observational
Preparation of oxime dual NK(1)/NK(2) antagonists with reduced NK(3) affinity.
PMID 12161132·Bioorg Med Chem Lett·2002
8-other
Structure-activity relationships of oxime neurokinin antagonists: oxime modifications.
PMID 11859013·Bioorg Med Chem Lett·2002
7-preclinical
Synthesis and structure-activity relationships of oxime neurokinin antagonists: discovery of potent arylamides.
PMID 11755340·Bioorg Med Chem Lett·2002
8-other
Plasma concentrations of soluble tumor necrosis factor receptor I and tumor necrosis factor during cardiopulmonary bypass.
PMID 11081891·Ann Thorac Surg·2000
8-other
The design and synthesis of novel NK1/NK2 dual antagonists.
PMID 11055349·Bioorg Med Chem Lett·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1202 MARTIN LUTHER KING JR WAY
TACOMA, WA 98405 - Phone
- (253) 441-4742
Quick Facts
- NPI
- 1235195017
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 46
- Publications
- 15
Are you this provider?
Claim Your Profile